Department of Surgery - Hepatopancreatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ann Surg Oncol. 2018 Apr;25(4):1034-1042. doi: 10.1245/s10434-017-6323-3. Epub 2018 Jan 29.
Pancreatic cancer is a highly lethal cancer with no established a priori markers of survival. Existing nomograms rely mainly on post-resection data and are of limited utility in directing surgical management. This study investigated the use of quantitative computed tomography (CT) features to preoperatively assess survival for pancreatic ductal adenocarcinoma (PDAC) patients.
A prospectively maintained database identified consecutive chemotherapy-naive patients with CT angiography and resected PDAC between 2009 and 2012. Variation in CT enhancement patterns was extracted from the tumor region using texture analysis, a quantitative image analysis tool previously described in the literature. Two continuous survival models were constructed, with 70% of the data (training set) using Cox regression, first based only on preoperative serum cancer antigen (CA) 19-9 levels and image features (model A), and then on CA19-9, image features, and the Brennan score (composite pathology score; model B). The remaining 30% of the data (test set) were reserved for independent validation.
A total of 161 patients were included in the analysis. Training and test sets contained 113 and 48 patients, respectively. Quantitative image features combined with CA19-9 achieved a c-index of 0.69 [integrated Brier score (IBS) 0.224] on the test data, while combining CA19-9, imaging, and the Brennan score achieved a c-index of 0.74 (IBS 0.200) on the test data.
We present two continuous survival prediction models for resected PDAC patients. Quantitative analysis of CT texture features is associated with overall survival. Further work includes applying the model to an external dataset to increase the sample size for training and to determine its applicability.
胰腺癌是一种高度致命的癌症,目前尚无明确的生存预后标志物。现有的列线图主要依赖于术后数据,对指导手术管理的实用性有限。本研究旨在探讨使用定量 CT(computed tomography)特征来术前评估胰腺导管腺癌(pancreatic ductal adenocarcinoma,PDAC)患者的生存情况。
从 2009 年至 2012 年连续前瞻性维护数据库中确定接受 CT 血管造影检查和胰腺切除术的化疗初治 PDAC 患者。使用纹理分析(一种已在文献中描述的定量图像分析工具)从肿瘤区域提取 CT 增强模式的变化。构建了两种连续生存模型,其中 70%的数据(训练集)使用 Cox 回归,首先仅基于术前血清肿瘤标志物 CA19-9 水平和图像特征(模型 A),然后基于 CA19-9、图像特征和 Brennan 评分(复合病理评分;模型 B)。其余 30%的数据(测试集)保留用于独立验证。
共纳入 161 例患者进行分析。训练集和测试集分别包含 113 例和 48 例患者。在测试数据中,定量图像特征与 CA19-9 相结合的模型的 c 指数为 0.69(综合 Brier 评分(integrated Brier score,IBS)为 0.224),而结合 CA19-9、成像和 Brennan 评分的模型的 c 指数为 0.74(IBS 为 0.200)。
我们提出了两种用于接受胰腺切除术的 PDAC 患者的连续生存预测模型。CT 纹理特征的定量分析与总生存相关。进一步的工作包括将模型应用于外部数据集,以增加训练样本量并确定其适用性。